Department of NeuroOncology, Moffitt Cancer Center
Tampa, United States
Michael A. Vogelbaum, MD, PhD, is Program Leader of NeuroOncology and Chief of Neurosurgery at Moffitt Cancer Center. He is also Professor of Oncological Sciences at the University of South Florida Morsani Medical School. He received his MD and PhD (Biomedical Engineering) from University of Virginia and completed his residency in neurosurgery at Barnes Hospital/Washington University in St. Louis. He spent nearly 20 years at the Cleveland Clinic where he was Associate Director of the Rose Ella Burkhardt Brain Tumor and NeuroOncology Center and held the Kathryn and Robert Lamborn Chair for NeuroOncology.
In addition to his active neurosurgery and radiosurgery practice, Dr. Vogelbaum has been Primary Investigator of numerous local and national clinical trials of new drugs and surgical techniques and devices for brain tumors. He has an externally funded basic science and translational research program which currently focuses on immunobiology of brain tumors, and various aspects of drug delivery to brain tumors. He is currently developing novel devices for delivering therapeutics directly to the brain, for which he has received multiple patents. The first of these devices has been introduced into clinical trials. He is the co-Founder and Chief Medical Officer of Infuseon Therapeutics, Inc., a company that was spun-off from the Cleveland Clinic to commercialize his therapeutic delivery devices.
Dr. Vogelbaum is a founder of the RANO (Response Assessment in NeuroOncology) group, Chair of the Neurosurgery Committee for NRG Oncology, and he has been a Vice President of the Society for NeuroOncology (SNO). He is a member of the editorial board for The Journal of Neurosurgery and the journals Neuro-Oncology and Neurosurgery, Tumor Section co-Editor of World Neurosurgery and he is co-Editor of the comprehensive textbook of neuro-oncology, Principles and Practice of Neuro-Oncology (2011).